Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 02-2023 | 11-2022 | 09-2022 | 08-2022 | 05-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,571 | 64,474 | 64,474 | 47,556 | 41,533 |
| Marketable Securities | 243,575 | 244,667 | 244,667 | 296,922 | 255,746 |
| TOTAL | $288,329 | $318,449 | $318,449 | $354,871 | $306,789 |
| Non-Current Assets | |||||
| PPE Net | 17,717 | 17,163 | 17,163 | 16,501 | 15,507 |
| Investments And Advances | 48,449 | 63,879 | 63,879 | 69,125 | 51,538 |
| Other Non-Current Assets | 15,659 | 17,268 | 17,268 | 18,841 | 20,476 |
| TOTAL | $81,825 | $98,310 | $98,310 | $104,467 | $87,521 |
| Total Assets | $370,154 | $416,759 | $416,759 | $459,338 | $394,310 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,629 | 5,064 | 5,064 | 6,053 | 6,142 |
| Accrued Expenses | 15,388 | 22,428 | 22,428 | 19,609 | 19,734 |
| TOTAL | $64,878 | $70,655 | $70,655 | $67,500 | $72,665 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 38,305 | 37,633 | 37,633 | 36,342 | 41,319 |
| Other Non-Current Liabilities | 5,106 | 6,434 | 6,434 | 7,745 | 9,043 |
| TOTAL | $31,224 | $42,408 | $42,408 | $49,293 | $54,906 |
| Total Liabilities | $96,102 | $113,063 | $113,063 | $116,793 | $127,571 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,445 | 47,273 | N/A | 47,148 | 47,042 |
| Common Shares | 47 | 47 | 47 | 47 | 45 |
| Retained earnings | -441,985 | -401,252 | -401,252 | -354,535 | -308,826 |
| Other shareholders' equity | -3,247 | -4,319 | -4,319 | -3,742 | -3,085 |
| TOTAL | $274,052 | $303,696 | $303,696 | $342,545 | $266,739 |
| Total Liabilities And Equity | $370,154 | $416,759 | $416,759 | $459,338 | $394,310 |